Synaffix BV
  1. Companies
  2. Synaffix BV
  3. Products
  4. GlycoConnect - Bispecific Antibody

GlycoConnectBispecific Antibody

SHARE

Enabling immune cell engagers & other protein conjugates.

Most popular related searches
  • Novel 2:1 format expected to deliver safety advantage
  • Avoid co-expressing a genetic fusion of two separate antibodies / binding domains
  • Directly convert any off-the-shelf antibody into a bispecific

Non-genetic Approach to Bispecifics

We use GlycoConnect™ to conjugate a separate antibody binding domain or cytokine (similar to an ADC payload), enabling bispecific immune cell engagers or checkpoint inhibitors from full-sized antibodies.